Los puntos clave no están disponibles para este artículo en este momento.
According to the Physicians' Desk Reference (PDR), 36% of modern antihypertensive and antihyperlipidemic drugs produce untoward alterations in chemosensory perception. Such disturbances can adversely affect the quality of life, produce non-compliance to medication schedules, and may result in decreased food intake, loss of appetite, weight decrement, and depression. This review lists the primary antihypertensive and antihyperlipidemic drugs that adversely alter chemosensory function, provides information on better defining the nature of the dysfunction, outlines testing strategies and available tests that could be used to better define the prevalence of the dysfunction, and summarizes means for mitigating such alterations.
Doty et al. (Fri,) studied this question.